KBI: KBI Biopharma and Infinimmune partner to produce human monoclonal antibodies
The collaboration will advance the manufacturing of Infinimmune's lead human monoclonal antibody programme targeting atopic dermatitis
Read full article »
KBI is a North Carolina-based contract development organization that provides services such as cell line development and clinical manufacturing for the pharmaceutical sector.
Read more